Blepharitis clinical trials

The registry lists 73 studies for Blepharitis across more than 10 countries. 9 are recruiting or about to start. 54 of them are mainly about Blepharitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.

Get an email when these change. Save the Blepharitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 47
Status unknown: 9
Recruiting: 6
Terminated: 6
Not yet recruiting: 3
Active, not recruiting: 1

Phase

Phase 2: 16
Phase 4: 15
Phase 3: 11
Phase 1: 2

Where

United States: 39
Italy: 6
China: 3
United Kingdom: 3
Brazil: 3
Guatemala: 2

Who runs them

Merck Sharp & Dohme LLC (7) · Tarsus Pharmaceuticals, Inc. (5) · Federal University of São Paulo (2) · Alcon Research (2) · Laboratoires Thea (2) · Aperta Biosciences, LLC (2) · University of Texas Southwestern Medical Center (2) · Nicox Ophthalmics, Inc. (2)

What is being tested here

Drugs under test in Blepharitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Spinosad	1	0	2
Azithromycin	0	0	10
TP-03	0	2	3
Loteprednol Etabonate	0	1	3
Lotilaner	0	1	2
Tobramycin	0	1	2
Moxifloxacin	0	1	2
Dexamethasone	0	1	2
Moxidectin	0	0	1
Fluticasone	0	0	1

Drug classes tested here Corticosteroids 4

Coming up

0phase 3 studies under way

3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Jan 2027A Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis · Aperta Biosciences, LLC
Mar 2027Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study · Brent Kramer
Mar 2027Ocular Dysbiosis in Eyelid Disease · Brent Kramer

Who these studies take

Of the 6 Blepharitis studies recruiting now, 6 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	0 (0%)	0 (0%)
18	6 (100%)	6 (100%)
30	6 (100%)	6 (100%)
40	6 (100%)	6 (100%)
50	6 (100%)	6 (100%)
65	6 (100%)	6 (100%)
75	6 (100%)	6 (100%)
85	6 (100%)	6 (100%)

Across all 73 studies, recruiting or not: 7% stop at 75 or younger and 4% at 65; 14% take children; 0% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

A Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With BlepharitisOct 29, 2026NCT07904767

Studies

Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 → or search them.